Proceedings of the Consensus Conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, Pennsylvania
A consensus conference on the role of sentinel node biopsy in breast carcinoma was held in Philadelphia, April 19‐22, 2001. The current report summarizes the deliberations of the group and advances its current guidelines for the integration of this new technique into contemporary clinical practice....
Saved in:
Published in | Cancer Vol. 94; no. 10; pp. 2542 - 2551 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
New York
Wiley Subscription Services, Inc., A Wiley Company
15.05.2002
Wiley-Liss |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A consensus conference on the role of sentinel node biopsy in breast carcinoma was held in Philadelphia, April 19‐22, 2001. The current report summarizes the deliberations of the group and advances its current guidelines for the integration of this new technique into contemporary clinical practice. |
---|---|
Bibliography: | Fax: (215) 627‐3925 The Consensus Conference Committee members, who were all authors for this article, were: Gordon F. Schwartz (Co‐chair), M.D., M.B.A., Jefferson Medical College; Armando E. Giuliano (Co‐chair), M.D., John Wayne Cancer Institute; Blake Cady, M.D., Womens & Infants Hospital; Luigi Cataliotti, M.D., Policlinico di Pareggi, Florence; Krishna B. Clough, M.D., Institut Curie, Paris; Hiram S. Cody III, M.D., Memorial Sloan‐Kettering Cancer Center; Edward M. Copeland III, M.D., University of Florida College of Medicine; Charles E. Cox, M.D., University of South Florida Moffitt Cancer Center; Gerard M. Doherty, M.D., Washington University School of Medicine; Michael Edwards, M.D., James Brown Cancer Center; Sheldon Feldman, M.D., Cancer Center of Beth Israel Medical Center; Ian S. Fentiman, M.D., Guy's Hospital, London; Kevin Fox, M.D., University of Pennsylvania School of Medicine; Fred Gorstein, M.D., Thomas Jefferson University Hospital; Daniel Hayes, M.D., University of Michigan Comprehensive Cancer Center; Daniel B. Kopans, M.D., Harvard Medical School; Michael D. Lagios, M.D., St. Mary's Medical Center, San Francisco; Robert E. Mansel, M.B.B.S., M.S., University of Wales College of Medicine; Shahla Masood, M.D., University of Florida Health Science Center; David L. Page, M.D., Vanderbilt University Medical Center; Juan Palazzo, M.D., Thomas Jefferson University Hospital; Peter I. Pressman, M.D., Weill Medical College of Cornell University; Emiel J. Th. Rutgers, M.D., Netherlands Cancer Institute; Bruno Salvadori, M.D., Policlinico San Marco, Bergamo; Melvin J. Silverstein, M.D., University of Southern California (USC)/Keck School of Medicine, USC/Norris Comprehensive Cancer Center; Lawrence J. Solin, M.D., University of Pennsylvania School of Medicine; Daniela Terribile, M.D., Università Cattolica Sacro Cuore, Rome; Michael Untch, M.D., University of Munich; Umberto Veronesi, M.D., European Institute of Oncology, Milan; W. A. Waddington, B.Sc., M.Sc., Institute of Nuclear Medicine, University College London; James A. Waldron, M.D., University of Arkansas for Medical Sciences; David J. Winchester, M.D., Northwestern University Medical School. SourceType-Scholarly Journals-1 ObjectType-News-2 content type line 23 ObjectType-Review-1 ObjectType-Conference-3 ObjectType-Feature-5 ObjectType-Article-4 |
ISSN: | 0008-543X 1097-0142 |
DOI: | 10.1002/cncr.10539 |